SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.

Category: Cardiovascular

Category Search

visual bubble
visual bubble
visual bubble
visual bubble

A Multicenter Evaluation of Survival After In-Hospital Cardiac Arrest in Coronavirus Disease 2019 Patients

From Critical Care Explorations.  In-hospital cardiac arrest survival among coronavirus disease 2019 patients has been reported to range from 0% to 12% -- significantly lower than reported prepandemic in-hospital cardiac arrest survival rates of approximately 20% to 25% in the United States for non–coronavirus disease 2019 patients. In this multi-center study, the authors report a 22% survival to discharge after in-hospital cardiac arrest in coronavirus disease 2019 patients, a survival rate similar with before the coronavirus disease 2019 pandemic.


If a patient develops hypotension in the emergency department, how should this be addressed?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on May 12th, 2021


Editorial: Coronavirus Disease 2019: There Is a Heart Between the Lungs

From Critical Care Medicine. This Editorial was written in response to the article by Chotalia et al. “Right Ventricular Dysfunction and Its Association With Mortality in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.”


VTE and COVID-19; Anti-Xa Monitoring in VTE Prophylaxis: Is There a Role?

Controversies in VTE Prophylaxsis; Xa Monitoring for VTE Prophylaxis. This is SCCM curated COVID-19 microlearning content.

Curriculum Topic: Cardiovascular Complications: Venous Thromboembolism, Myocarditis, and Shock


Online Letter to the Editor: The Intriguing, Still Undercovered, Clinical Role of Echocardiography in Critically Ill Coronavirus Disease Patients

From Critical Care Medicine. This Online Letter to the Editor was written in response to an article by  Chotalia et al. entitled “Right ventricular dysfunction and its association with mortality in coronavirus disease 2019 acute respiratory distress syndrome.”


Online Letter to the Editor: Right Ventricular Dysfunction and Its Association With Mortality in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: Do Not Focus on Not Reliable Markers

From Critical Care Medicine. This is an Online Letter to the Editor written in response to Right Ventricular Dysfunction and Its Association With Mortality in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome by Chotalia et al.


Arterial Ischemia in COVID-19; Is Ischemic Stroke More Prevalent with COVID?

Dr. Daniel Temas from Prisma Health will present a case study presentation.  Paul Nyquist, MD,  from MPH, the Johns Hopkins University School of Medicine, will provide an update on Stroke literature related to COVID and speak to thrombosis and Ischemic stroke impact. 

Curriculum Topic: Cardiovascular Complications: Venous Thromboembolism, Myocarditis, and Shock


Concise Critical Appraisal: Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest

Although several trials have examined in-hospital cardiac arrest (IHCA), only two trials in the past decade have examined the use of vasopressin and glucocorticoids for IHCA. Both trials found improved survival and favorable neurologic outcome with a vasopressin-epinephrine-methylprednisolone combination. Because of a lack of additional supporting evidence, neither the American nor European international guidelines have recommended this combination for IHCA. This Concise Critical Appraisal examines an article by Andersen et al that attempted to validate the results of these trials.
 


Concise Critical Appraisal: Epinephrine Dosing Intervals on Outcomes From Pediatric In-Hospital Card

The average annual incidence of pediatric in-hospital cardiac arrest (IHCA) has recently been estimated at more than 15,000 cases.1 Survival rates for pediatric patients who have had pulseless cardiac arrest have remained below 50% for the past decade.2,3 The American Heart Association currently recommends epinephrine, the cornerstone medication for cardiac arrest, dosed every 3 to 5 minutes in adult and pediatric cardiac arrest, although there is conflicting evidence about whether this is the best interval.4,5 Epinephrine is believed to acutely increase coronary perfusion pressure by increasing diastolic blood pressure (DBP).


Concise Critical Appraisal: Early Hemostatic Management of Disseminated Intravascular Coagulopathy

This Concise Critical Appraisal delves into a study published in Pediatric Critical Care Medicine that sought to determine whether early hemostatic intervention can prevent the development of DIC and improve outcomes.


SCCM Pod-460 CCE: Multiple PCR for Direct Detection of Bloodstream Infection After Pediatric Cardiac Surgery

Nosocomial infections are a prevalent cause of death and complications in critically ill children. Conventional cultures are able to detect only up to 25% of bacteremias. Several studies have suggested that molecular tests could be a faster and effective tool for detection of bacterial infections. Marilyn N. Bulloch, PharmD, BCPS, FCCM, is joined by Sylvia Belda Hofheinz, MD, to discuss the article, “Multiple Polymerase Chain Reaction for Direct Detection of Bloodstream Infection After Cardiac Surgery in a PICU,” published in the June 2022 issue of Critical Care Explorations (Checa RMC, et al. Crit Care Explor. 2022;4:e0707). Dr. Hofheinz is a physician in the pediatric ICU at University Hospital 12 de Octubre in Madrid, Spain.


SCCM Pod-488: Getting to the Heart of the National Board of Echocardiography Examination

The National Board of Echocardiography has developed an examination to assess echocardiography and ultrasound skills, which are required by many medical programs. Diane C. McLaughlin, DNP, AGACNP-BC, CCRN, FCCM, was joined by Sara Nikravan, MD, FASE, FCCM, at the 2023 Critical Care Congress to discuss advanced echocardiography and the National Board of Echocardiography examination. Sara Nikravan, MD, FASE, FCCM, is director of point-of-care ultrasound and associate program director of residency at the University of Washington in Seattle, Washington, USA. This podcast is sponsored by Echonous.


Push-Dose Vasopressor Safety and Efficacy

Are push-dose vasopressors (PDPs) safe and effective for patients with hypotension outside the operating room? This Concise Critical Appraisal covers a recent study that sought to determine whether phenylephrine and epinephrine are effective for acute hypotensive periods when PDP protocols are in place.


Hypotension: Non-ICU Emergency Cards

This resource details how manage hypotension. This is SCCM curated COVID-19 microlearning content.


How is ECMO being used in patients with COVID-19?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered.


ECMO in COVID-19

This presentation is an overview of using ECMO for COVID -19 patients. This is SCCM curated COVID-19 microlearning content.